BioSpace News Archive

Global professional services firm ZS has been selected by leading biopharmaceutical company Bristol Myers Squibb (BMS) (NYSE: BMY) to support its worldwide commercial analytics organization.

Altamira Therapeutics Ltd., a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, announced that its Chairman and CEO, Thomas Meyer, will present at the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022.

CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced positive results from the 350 mg weekly dose of its Phase 2 NASH clinical trial.

Department of Defense now able to Move Forward on Brain Plasticity Research.

The corporate presentation will be available on-demand and accessible from the Company’s Investor Relations website starting Monday January 10, 2022 at 7:00 am Eastern Time.

Tarsier Pharma, an advanced clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics for blinding ocular diseases, announced that it has launched an education website about the disease uveitic glaucoma at www.uveiticglaucoma.com, as a service to the public.

Buntanetap, previously known as ANVS401 or Posiphen, is sometimes mistaken for phenserine.

Cantabio Pharmaceuticals, Inc. announced that The Michael J. Fox Foundation for Parkinson’s Research has awarded the Company a major grant for a project entitled “Development of small-molecule inhibitors to reduce the aggregation of tau for the treatment of Parkinson’s disease.”

Carisma Therapeutics Inc., a biopharmaceutical pioneer in engineered macrophage-based therapeutics, today announced that Steven Kelly, President and Chief Executive Officer of Carisma, will present at the 40th Annual J.P. Morgan Healthcare Conference.

Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak™ report on industry leaders in diagnostic imaging equipment in the United States.